updat sales/ep estim
exhibit given addit entellu sale
higher orthoped slightli off-set less favor fx gm/om increas
 result benefit slightli off-set
higher tax rate vs prior estim compar consensu
 management organ growth guidanc
ep rang
anticip anoth strong year us knee model us knee
growth in-lin cy versu underli market growth
given momentum busi wouldnt shock see
upsid estim past year gain approxim
us knee share exhibit tri pars variou contributor syk
us share gain assign direct mako gain
non- account mako asp uplift account
mako pull-through/oth ascrib increment cement-less
knee mix note mako tka adopt facilit increment
convers cement-less knee given improv precis tibial cut
achiev robot
valuat risk like syk reliabl strong sale growth
diversif well upsid potenti via futur accret mako
share gain use rel valuat framework regress
forward sale compound-annual-growth-rate vs rel forward peer price-to-earnings ascrib rel
forward price-to-earnings premium convolv day forward
multipl anticip cash earn arriv
revis price target risk target price includ
inabl mako drive share gain hospit capital-expenditure declin failur deliv
margin expans experi eros due acquisit activ
downward reset somewhat inflat market multipl
continu pg
tr target
exhibit revenu varianc segment product categori
page
strh estimatesstrhconsensusno ofstrh vs consensu cc pt handl emerg spineneurotechnolog neurotechnolog total stryker corpor
exhibit contributor syk us knee share gain
per commentari call unit competit surgeon new triathlon knee robot place competit
domin account assum mako tka unit increment inclus unit consum previou low mix
page
incom statementstrh estimatesstrhconsensusno ofstrh vs consensu cc estimatesstrhconsensusno ofstrh vs consensusmargin knee share due imput makou knee share gain directli attribut competit gainmako asp impact accountsimpact cement-less kneepul othermako tka presum tka presum tka tka robot place usu tka mako tka mako tka tka asp premium assumedmako asp premium mix convert cementless tka revenu mako cementless compeit cement-less revenu revenu revenu market market us knee market share market share stryker corpor
page
incom inc med-tech w/ analysisgross analysissal cc extrem orthoped total neurotech spine ep stryker corpor
global compani provid medic technolog product servic busi
segment orthoped medsurg neurotechnolog spine compani found
homer stryker incorpor headquart kalamazoo mi
believ strength brand us compani proven abil maxim
impact acquir technolog busi upon incorpor syk excel commerci
organ support target price
valuat risk
like syk reliabl strong sale growth diversif well upsid potenti via futur
accret mako share gain use rel valuat framework regress
forward sale compound-annual-growth-rate vs rel forward peer price-to-earnings ascrib rel forward price-to-earnings premium
convolv day forward multipl anticip cash
earn arriv price target risk target price includ inabl
mako drive share gain hospit capital-expenditure declin failur deliv margin expans experi
eros due acquisit activ downward reset somewhat inflat market
compani mention note
bruce nudel herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
